Literature DB >> 16900791

Leptin alterations in the course of sepsis in humans.

M Tzanela1, S E Orfanos, M Tsirantonaki, A Kotanidou, Ch Sotiropoulou, M Christophoraki, D Vassiliadi, N C Thalassinos, Ch Roussos.   

Abstract

Neuroendocrine response to sepsis may be divided into acute and prolonged phase. As leptin is implicated in the stress response, leptin's profile during both phases, and the possible relationships between leptin and the neuroendocrine response to sepsis were investigated. Thirty adult patients with sepsis in an intensive care unit were studied. Blood samples were collected at the acute and the prolonged phases. In acute sepsis, leptin levels were higher in patients than in controls (10.2 +/- 2.5 vs. 4.1 +/- 1.2 ng/ml, p =0.01) and correlated positively with insulin levels and insulin resistance. A decline in leptin levels was found during prolonged sepsis (from 10.2 +/- 2.5 to 6.2 +/- 1.7 ng/ml, p=0.001), which was not related to survival (p=0.913). At the onset of sepsis, leptin levels increased in correlation with insulin and insulin resistance, possibly indicating a cause-effect relationship. However, the decline in leptin levels during the prolonged phase of sepsis was not related either to survival or to metabolic and hormonal changes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16900791

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  12 in total

1.  Thermogenic response and leptin levels rise after recovery of the euthyroid state.

Authors:  F Saraç; A Gökhan Ozgen; G Celebi; M Pehlivan; H Uluer; C Yilmaz
Journal:  J Endocrinol Invest       Date:  2009-10-15       Impact factor: 4.256

2.  Less is more in nutrition: critically ill patients are starving but not hungry.

Authors:  Yaseen M Arabi; Annika Reintam Blaser; Jean-Charles Preiser
Journal:  Intensive Care Med       Date:  2019-09-17       Impact factor: 17.440

Review 3.  The Role of Adipose Tissue and Adipokines in Sepsis: Inflammatory and Metabolic Considerations, and the Obesity Paradox.

Authors:  Irene Karampela; Gerasimos Socrates Christodoulatos; Maria Dalamaga
Journal:  Curr Obes Rep       Date:  2019-12

4.  Apical leptin induces chloride secretion by intestinal epithelial cells and in a rat model of acute chemotherapy-induced colitis.

Authors:  M Raschid Hoda; Michael Scharl; Stephen J Keely; Declan F McCole; Kim E Barrett
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-04       Impact factor: 4.052

Review 5.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

6.  Sepsis-Induced Adipokine Change with regard to Insulin Resistance.

Authors:  Andreas Hillenbrand; Manfred Weiss; Uwe Knippschild; Anna Maria Wolf; Markus Huber-Lang
Journal:  Int J Inflam       Date:  2012-01-09

Review 7.  The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis.

Authors:  Sven H Loosen; Alexander Koch; Frank Tacke; Christoph Roderburg; Tom Luedde
Journal:  Int J Mol Sci       Date:  2019-09-28       Impact factor: 5.923

8.  Leptin, Ghrelin, and Leptin/Ghrelin Ratio in Critically Ill Patients.

Authors:  Yaseen M Arabi; Dunia Jawdat; Hasan M Al-Dorzi; Hani Tamim; Waleed Tamimi; Abderrezak Bouchama; Musharaf Sadat; Lara Afesh; Mashan L Abdullah; Walid Mashaqbeh; Maram Sakhija; Abdulaziz Al-Dawood
Journal:  Nutrients       Date:  2019-12-21       Impact factor: 5.717

Review 9.  Serum leptin level as a diagnostic and prognostic marker in infectious diseases and sepsis: A comprehensive literature review.

Authors:  Victoria Birlutiu; Loredana Camelia Boicean
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

10.  Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin.

Authors:  Lies Langouche; Sarah Vander Perre; Jan Frystyk; Allan Flyvbjerg; Troels Krarup Hansen; Greet Van den Berghe
Journal:  Crit Care       Date:  2009-07-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.